ATE205736T1 - Stabilisierte zwischenschicht für iontophorese - Google Patents

Stabilisierte zwischenschicht für iontophorese

Info

Publication number
ATE205736T1
ATE205736T1 AT96104195T AT96104195T ATE205736T1 AT E205736 T1 ATE205736 T1 AT E205736T1 AT 96104195 T AT96104195 T AT 96104195T AT 96104195 T AT96104195 T AT 96104195T AT E205736 T1 ATE205736 T1 AT E205736T1
Authority
AT
Austria
Prior art keywords
drug
water
soluble protein
matrix
iontophoresis
Prior art date
Application number
AT96104195T
Other languages
English (en)
Inventor
Katsumi Iga
Masafumi Misaki
Keiichiro Okabe
Emi Kyo
Original Assignee
Hisamitsu Pharmaceutical Co
Advance Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co, Advance Co Ltd filed Critical Hisamitsu Pharmaceutical Co
Application granted granted Critical
Publication of ATE205736T1 publication Critical patent/ATE205736T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/249921—Web or sheet containing structurally defined element or component
    • Y10T428/249953—Composite having voids in a component [e.g., porous, cellular, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
AT96104195T 1995-03-17 1996-03-15 Stabilisierte zwischenschicht für iontophorese ATE205736T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8629195 1995-03-17

Publications (1)

Publication Number Publication Date
ATE205736T1 true ATE205736T1 (de) 2001-10-15

Family

ID=13882743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96104195T ATE205736T1 (de) 1995-03-17 1996-03-15 Stabilisierte zwischenschicht für iontophorese

Country Status (5)

Country Link
US (1) US5837281A (de)
EP (1) EP0732122B1 (de)
AT (1) ATE205736T1 (de)
CA (1) CA2171909A1 (de)
DE (1) DE69615243T2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4154016B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置およびその組み立て方法
JP4154017B2 (ja) * 1997-12-30 2008-09-24 久光製薬株式会社 イオントフォレーシス装置および薬物ユニット
JPH11239621A (ja) * 1998-02-25 1999-09-07 Hisamitsu Pharmaceut Co Inc イオントフォレーシス装置
US6643544B1 (en) * 1999-04-12 2003-11-04 Hisamitsu Pharmaceutical Co., Inc. Iontophoresis device
EP2213743A1 (de) * 2000-04-12 2010-08-04 Human Genome Sciences, Inc. Albuminfusionsproteine
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
US6629968B1 (en) * 2000-06-30 2003-10-07 Vyteris, Inc. Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system incorporating the reservoir-electrode
US20040057983A1 (en) 2002-09-25 2004-03-25 David Schmidt Biomolecular wearable apparatus
EP1648596B1 (de) * 2003-06-02 2010-02-17 GE Osmonics, Inc. Materialien zum verarbeiten nicht-wässeriger mischungen und verfahren zu deren herstellung
IL159273A0 (en) * 2003-12-09 2004-06-01 Transpharma Medical Ltd Transdermal delivery system for sustained release of polypeptides
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
US20070250018A1 (en) * 2004-08-12 2007-10-25 Hirotoshi Adachi Transdermal Drug Administration System with Microneedles
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
US20080274166A1 (en) * 2005-06-10 2008-11-06 Transpharma Medical Ltd. Patch for Transdermal Drug Delivery
JP2009509657A (ja) 2005-09-30 2009-03-12 Ｔｔｉ・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
US20070083185A1 (en) * 2005-09-30 2007-04-12 Darrick Carter Iontophoretic device and method of delivery of active agents to biological interface
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
JP2009531324A (ja) 2006-03-20 2009-09-03 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 癌標的化のための操作された抗前立腺幹細胞抗原（ｐｓｃａ）抗体
WO2008005458A2 (en) * 2006-07-05 2008-01-10 Tti Ellebeau, Inc. Delivery device having self-assembling dendritic polymers and method of use thereof
US8048044B2 (en) * 2007-08-14 2011-11-01 Stryker Corporation Drug delivery system
US20120065576A1 (en) * 2007-08-14 2012-03-15 Stryker Corporation Drug delivery system
CA2698343C (en) * 2007-09-04 2018-06-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
US20100293807A1 (en) * 2007-10-29 2010-11-25 Transpharma Medical, Ltd. Vertical patch drying
US8602961B2 (en) 2008-05-15 2013-12-10 Lifewave Products Llc Apparatus and method of stimulating elevation of glutathione levels in a subject
TW201043287A (en) * 2009-05-08 2010-12-16 Isis Biopolymer Llc Iontophoretic device with improved counterelectrode
US20110092881A1 (en) * 2009-05-08 2011-04-21 Isis Biopolymer Inc. Iontophoretic device with contact sensor
US10238847B2 (en) * 2014-01-22 2019-03-26 Geelux Holdings, Ltd. Devices and methods for transdermal drug delivery

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
FR2238700B1 (de) 1973-07-24 1977-10-14 Takeda Chemical Industries Ltd
JPS5726506B2 (de) 1974-03-08 1982-06-04
AT347054B (de) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
FR2329293A1 (fr) 1975-10-29 1977-05-27 Parke Davis & Co Nouveaux nonapeptides et procedes pour leur production
US4087390A (en) 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4093574A (en) 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
JPS5944308B2 (ja) 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4124577A (en) 1977-06-13 1978-11-07 Warner-Lambert Nonapeptides and methods for their production
US4253998A (en) 1979-03-09 1981-03-03 American Home Products Corporation Peptides related to somatostatin
JPS54148722A (en) 1978-05-12 1979-11-21 Takeda Chem Ind Ltd Nonapeptide and its preparation
US4317815A (en) 1979-06-13 1982-03-02 Coy David Howard LH-RH Antagonists
US4253997A (en) 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
JPS5692846A (en) 1979-12-27 1981-07-27 Takeda Chem Ind Ltd Tetrapeptide derivative and its preparation
US4424210A (en) 1980-04-04 1984-01-03 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4328319A (en) * 1980-10-27 1982-05-04 Restech Research Limited Partnership Process for preparing propellant compositions forming foamed structures containing open and/or closed cells
US4738849A (en) * 1984-06-28 1988-04-19 Interface Biomedical Laboratories Corp. Composite medical articles for application to wounds and method for producing same
US5407685A (en) * 1986-02-06 1995-04-18 Steris Corporation Controlled oxygen/anti-microbial release films
US5250022A (en) * 1990-09-25 1993-10-05 Rutgers, The State University Of New Jersey Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US4876332A (en) * 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
US4897811A (en) 1988-01-19 1990-01-30 Nestor, Inc. N-dimensional coulomb neural network which provides for cumulative learning of internal representations
EP0682020A1 (de) 1988-09-01 1995-11-15 Takeda Chemical Industries, Ltd. Fumagillolderivate verwendbar als Angiogeneseinhibitoren
CA1329771C (en) 1988-09-01 1994-05-24 Shoji Kishimoto Angiogenesis inhibitory agent
ATE97410T1 (de) 1989-03-06 1993-12-15 Takeda Chemical Industries Ltd 6-amino-6-desoxyfumagillole, ihre herstellung und ihre verwendung.
JP2719671B2 (ja) * 1989-07-11 1998-02-25 日本ゼオン株式会社 創傷被覆材
EP0415294A3 (en) 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
US5167616A (en) * 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US5344702A (en) * 1990-09-14 1994-09-06 Hoechst Celanese Corp. Coated fibers
USH1160H (en) * 1990-11-26 1993-04-06 Iontophoretic delivery of peptides
US5152996A (en) * 1990-12-10 1992-10-06 Eastman Kodak Company Nonwoven wipes impregnated with an aqueous solution of a zinc acetate peroxide and a surfactant
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
JPH0616535A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼ用インターフェイス
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
EP0643981B1 (de) * 1993-09-22 2002-01-09 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix

Also Published As

Publication number Publication date
DE69615243D1 (de) 2001-10-25
EP0732122B1 (de) 2001-09-19
DE69615243T2 (de) 2002-06-27
CA2171909A1 (en) 1996-09-18
EP0732122A1 (de) 1996-09-18
US5837281A (en) 1998-11-17

Similar Documents

Publication Publication Date Title
DE69615243D1 (de) Stabilisierte Zwischenschicht für Iontophorese
ATE248004T1 (de) Schnittstelle für iontophorese
ATE133078T1 (de) Einrichtung zur transdermalen wirkstoffabgabe
CY1114000T1 (el) Σταθεροποιημενα διαλυματα τεριπαρατιδης
MX9502034A (es) Formulacion estable, liofilizada, que comprende una proteina y equipo de dosificacion.
ATE255450T1 (de) Matrix für iontophorese
FI973452A0 (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
HU900108D0 (en) Composition of controlled active ingredient delivery, operating by hydrogel
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
BG42182A3 (en) Vaginal ring
NO994087L (no) Vedvarende analgesi oppnaadd med buprenorfin
ATA214488A (de) Dosierungsform zur schnellen abgabe eines wirkstoffes gefolgt von einer langsamen abgabe eines wirkstoffes
GR3015363T3 (en) Use of a heavily soluble salt of a heteropolyacid for the determination of an analyte a corresponding assay and means useful therefor.
IT8567165A1 (it) Composizioni a base di liposomi, particolarmente per mantenere ed immobilizzare una riserva di agenti biologicamente attivi, e relativo procedimento d'impiego.
EP0305551A3 (de) Pharmazeutische Zusammensetzungen zur topischen Anwendung
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
DK156289A (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
DE3571552D1 (en) Preparation containing stabilized polypeptide having gamma-interferon activity
AU7284098A (en) Method for preventing gastritis using amylin or amylin agonists
DE3587794D1 (de) Pharmazeutische Präparate.
TR199903069T2 (xx) Etkin madde olarak bir ace inhibit�r� i�eren kontroll�-sal�m farmas�tik preparat�.
CA2242224A1 (fr) Microgranules a liberation prolongee contenant du diltiazem comme principe actif
Bozou et al. Phorbol ester induces loss of VIP stimulation of adenylate cyclase and VIP‐binding sites in HT29 cells
KR920018076A (ko) 신규 폴리펩티드
Diliberto et al. Interrelationships of platelet‐derived growth factor isoform‐induced changes in c‐fos expression, intracellular free calcium, and mitogenesis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties